1. 30 NLR (neutrophil lymphocyte ratio) and PLR (platelet lymphocyte ratio) changes as a predictor of eventual treatment failure and death on nivolumab therapy in renal cell carcinoma. (10th December 2020) Authors: Basu, Arnab; Suri, Yash; Nandagopal, Lakshminarayan; Deshazo, Mollie; Norian, Lyse; Yang, Eddy Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adjuvant stereotactic body radiotherapy following transarterial chemoembolization in patients with non‐resectable hepatocellular carcinoma tumours of ≥3 cm. Issue 2 (4th September 2014) Authors: Jacob, Rojymon; Turley, Falynn; Redden, David T.; Saddekni, Souheil; Aal, Ahmed K. A.; Keene, Kimberly; Yang, Eddy; Zarzour, Jessica; Bolus, David; Smith, J. Kevin; Gray, Stephen; White, Jared; Eckhoff, Devin E.; DuBay, Derek A. Journal: HPB Issue: Volume 17:Issue 2(2015:Feb.) Page Start: 140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adjuvant stereotactic body radiotherapy following transarterial chemoembolization in patients with non‐resectable hepatocellular carcinoma tumours of ≥3 cm. Issue 2 (February 2015) Authors: Jacob, Rojymon; Turley, Falynn; Redden, David T.; Saddekni, Souheil; Aal, Ahmed K.A.; Keene, Kimberly; Yang, Eddy; Zarzour, Jessica; Bolus, David; Smith, J. Kevin; Gray, Stephen; White, Jared; Eckhoff, Devin E.; DuBay, Derek A. Journal: HPB Issue: Volume 17:Issue 2(2015:Feb.) Page Start: 140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Enhancement of Cetuximab-Induced Radiosensitization by JAK-1 Inhibition. Issue 1 (December 2015) Authors: Bonner, James; Trummell, Hoa; Bonner, Andrew; Willey, Christopher; Bredel, Markus; Yang, Eddy Journal: BMC cancer Issue: Volume 15:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Enhancement of Cetuximab-Induced Radiosensitization by JAK-1 Inhibition. Issue 1 (December 2015) Authors: Bonner, James; Trummell, Hoa; Bonner, Andrew; Willey, Christopher; Bredel, Markus; Yang, Eddy Journal: BMC cancer Issue: Volume 15:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Gene expression in primary and metastatic kidney cancer to discover drivers of metastasis and targets for drug development. (4th November 2015) Authors: Zhao, Amy; Guru, Arjun; Guru, Sonpavde; Yang, Eddy; Li, Yufeng Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Gene expression in primary and metastatic kidney cancer to discover drivers of metastasis and targets for drug development. Issue 2 (December 2015) Authors: Zhao, Amy; Guru, Arjun; Guru, Sonpavde; Yang, Eddy; Li, Yufeng Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Obesity diminishes response to PD-1-based immunotherapies in renal cancer. Issue 2 (22nd December 2020) Authors: Boi, Shannon K; Orlandella, Rachael M; Gibson, Justin Tyler; Turbitt, William James; Wald, Gal; Thomas, Lewis; Buchta Rosean, Claire; Norris, Katlyn E; Bing, Megan; Bertrand, Laura; Gross, Brett P; Makkouk, Amani; Starenki, Dmytro; Farag, Kristine I; Sorge, Robert E; Brown, James A; Gordetsky, Je... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗